<Suppliers Price>

2-Ethylhexyl trans-4-methoxycinnamate

Names

[ CAS No. ]:
83834-59-7

[ Name ]:
2-Ethylhexyl trans-4-methoxycinnamate

[Synonym ]:
UNII:F547714O0V
2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethylhexyl ester, (2Z)-
MFCD00072582
2-Ethylhexyl (2Z)-3-(4-methoxyphenyl)acrylate
4-methoxycinnamic acid 2-ethylhexyl ester
EINECS 226-775-7

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
405.3±20.0 °C at 760 mmHg

[ Molecular Formula ]:
C18H26O3

[ Molecular Weight ]:
290.397

[ Flash Point ]:
171.6±16.4 °C

[ Exact Mass ]:
290.188202

[ PSA ]:
35.53000

[ LogP ]:
5.66

[ Vapour Pressure ]:
0.0±0.9 mmHg at 25°C

[ Index of Refraction ]:
1.515

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
24/25-36-26

[ RIDADR ]:
NONH for all modes of transport

Articles

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

J. Sci. Ind. Res. 65(10) , 808, (2006)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...

Developing structure-activity relationships for the prediction of hepatotoxicity.

Chem. Res. Toxicol. 23 , 1215-22, (2010)

Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ...

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug Metab. Dispos. 38 , 2302-8, (2010)

Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti...


More Articles


Related Compounds